Spared caudal brainstem SERT binding in early Parkinson's disease

Postmortem data indicate loss of serotoninergic neurons in Parkinson's disease (PD). We used the serotonin transporter (SERT) radioligand 3-amino-4-(2-dimethylaminomethyl-phenylsulfaryl)-benzonitril (DASB) and positron emission tomography to examine SERT distribution and changes in early PD sub...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cerebral blood flow and metabolism Vol. 28; no. 3; pp. 441 - 444
Main Authors: Albin, Roger L, Koeppe, Robert A, Bohnen, Nicolaas I, Wernette, Kristine, Kilbourn, Michael A, Frey, Kirk A
Format: Journal Article
Language:English
Published: London, England SAGE Publications 01-03-2008
Lippincott Williams & Wilkins
Sage Publications Ltd
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Postmortem data indicate loss of serotoninergic neurons in Parkinson's disease (PD). We used the serotonin transporter (SERT) radioligand 3-amino-4-(2-dimethylaminomethyl-phenylsulfaryl)-benzonitril (DASB) and positron emission tomography to examine SERT distribution and changes in early PD subjects. We studied five PD subjects (H&Y 1 to 2.5) and eight normal controls. There is reduced SERT binding in PD. The magnitude of DASB binding reductions was greater in the forebrain than in the brainstem regions. There was no asymmetry of diminished SERT binding. DASB binding in the medulla was relatively spared, inconsistent with the description of early prominent pathologic study in these caudal brainstem nuclei.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0271-678X
1559-7016
DOI:10.1038/sj.jcbfm.9600599